Work

Clonal hematopoiesis of indeterminate potential is associated with reduced risk of cognitive impairment in patients with chronic kidney disease

Year: 2024
Type: article
Study design: Observational Study
Abstract: INTRODUCTION: Clonal hematopoiesis of indeterminate potential (CHIP) and dementia disproportionately burden patients with chronic kidney disease (CKD). The association between CHIP and cognitive impairment in CKD patients is unknown. METHODS: We conducted time-to-event analyses in up to 1452 older adults with CKD from the Chronic Renal Insufficiency Cohort who underwent CHIP gene sequencing. Cognition was assessed using four validated tests in up to 6 years mean follow-up time. Incident cognitive impairment was defined as a test score one standard deviation below the baseline mean. RESULTS: Compared to non-carriers, CHIP carriers were markedly less likely to experience impairment in attention (adjusted hazard ratio [HR] [95% confidence interval {CI}] = 0.44 [0.26, 0.76], p = 0.003) and executive function (adjusted HR [95% CI] = 0.60 [0.37, 0.97], p = 0.04). There were no significant associations between CHIP and impairment in global cognition or verbal memory. DISCUSSION: CHIP was associated with lower risks of impairment in attention and executive function among CKD patients. HIGHLIGHTS: Our study is the first to examine the role of CHIP in cognitive decline in CKD. CHIP markedly decreased the risk of impairment in attention and executive function. CHIP was not associated with impairment in global cognition or verbal memory.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,000
Awards: Associations of Mitochondrial DNA Alterations with Alzheimer's Disease Related Brain Health, Clinical and Translational Science Institute, American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC), Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Study, HiLo Competitive Renewal, G3340927746, General Clinical Research Center, G37449730, Using genomic modifiers to mechanistically link clonal hematopoiesis of indeterminate potential penetrance to coronary artery disease, Center for Clinical and Translational Science, Michigan Institute for Clinical and Health Research (MCHR), UPENN Scientific and Data Research Center for the HOPE Consortium to Reduce Pain and Opioid Use in Hemodialysis, Institute for Clinical and Translational Research, Institutional Clinical and Translational Science Award, G7958222963, Health Disparities in Chronic Kidney Disease Mentoring Program, G8287218166, Clinical and Translational Science Collaborative of Cleveland, G8534382735, G8676708184, Clinical and Translational Science Collaborative of Northern Ohio, Catalyzing Linkages for Everyone's Health (CLE Health), Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases, Prospective renal insufficiency cohort evaluation: PRICE, A Hybrid Type 1 Effectiveness-Implementation Study of Education Strategies for Vascular Access Creation in Advanced Kidney Disease, Chronic Renal Insufficiency Cohort (CRIC) Study Clinical Center, Continuation of the Chronic Renal Insufficiency Cohort (CRIC), Continuation of the University of Illinois Chicago CRIC Clinical Center, Clonal Hematopoiesis of Indeterminate Potential in Chronic Kidney Disease Patients, Short-Term Research Training Program in NIDDK Mission Areas, Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Hopkins Clinical Center, Tulane Clinical Center for Chronic Renal Insufficiency Cohort Study, Chronic Renal Insufficiency Cohort Limited competition continuation, Chronic Renal Insufficiency Cohort (CRIC) Study
OpenAlex ID: W4401422101
FWCI: 2.55
Cites: 38
Cited by: 13
Related to: 10